Search
InsiderInsights.com

Rawcliffe Adrian (1555851)

Rawcliffe Adrian has been a registered insider since 2003. As Chief Executive Officer at Adaptimmune Therapeutics plc , Rawcliffe Adrian last made a transaction on 1/17/2023.

(ADAP)

Titles: CEO,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
13 85% -8% -43% 433 1 Year 13 0% -- -- --
15 87% 2% -43% 635 9 Month 15 0% -- -- --
15 87% 21% -34% 716 6 Month 15 0% -- -- --
18 83% -16% -26% 169 3 Month 18 0% -- -- --
18 67% 6% -6% 271 1 Month 18 0% -- -- --
18 61% 10% -4% 234 1 Week 18 0% -- -- --
Scorecards Updated 6/9/2023 12:48 AM EST Latest Transaction Date: 1/17/2023
Average days between Transaction and Entered Dates: 1
© 2024 InsiderInsights.com